Literature DB >> 17426038

Differences in prognostic factors and survival among White men and Black men with prostate cancer, California, 1995-2004.

Anthony S Robbins1, Daixin Yin, Arti Parikh-Patel.   

Abstract

The authors conducted a study to determine whether differences in prostate cancer survival between White men and Black men are reduced or eliminated after accounting for differences in prognostic factors. Using population-based statewide cancer registry data, the authors analyzed data from a cohort of 122,375 non-Hispanic White men and Black men from California who were newly diagnosed with prostate cancer between 1995 and 2004 and followed through 2004. Compared with White men, Black men were characterized by younger age at diagnosis, more distant stage, less treatment with surgery or radiation therapy, higher tumor grades, lower neighborhood socioeconomic status, and more recent year of diagnosis. Adjusted only for age, the hazard ratio for prostate cancer death (Blacks vs. Whites) was 1.61 (95% confidence interval (CI): 1.50, 1.72). Additional adjustment for potentially modifiable factors (stage and treatment) eliminated most of the racial difference in survival (adjusted hazard ratio = 1.10, 95% CI: 1.03, 1.18). The racial difference in survival was completely eliminated after further adjustment for other factors (grade, socioeconomic status, and year of diagnosis) (adjusted hazard ratio = 0.99, 95% CI: 0.92, 1.06). Thus, the large difference in prostate cancer survival between White men and Black men was completely explained by known prognostic factors, with potentially modifiable disparities playing the largest role.

Entities:  

Mesh:

Year:  2007        PMID: 17426038     DOI: 10.1093/aje/kwm052

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  33 in total

1.  Increased racial differences on breast cancer care and survival in America: historical evidence consistent with a health insurance hypothesis, 1975-2001.

Authors:  Kevin M Gorey; Isaac N Luginaah; Kendra L Schwartz; Karen Y Fung; Madhan Balagurusamy; Emma Bartfay; Frances C Wright; Uzoamaka Anucha; Renee R Parsons
Journal:  Breast Cancer Res Treat       Date:  2008-03-11       Impact factor: 4.872

2.  Ethnic disparities in Americans of European descent versus Americans of African descent related to polymorphic ERCC1, ERCC2, XRCC1, and PARP1.

Authors:  Rui Gao; Douglas K Price; Tristan Sissung; Eddie Reed; William D Figg
Journal:  Mol Cancer Ther       Date:  2008-05       Impact factor: 6.261

3.  8q24 risk alleles and prostate cancer in African-Barbadian men.

Authors:  Cheryl D Cropp; Christiane M Robbins; Xin Sheng; Anselm J M Hennis; John D Carpten; Lyndon Waterman; Ronald Worrell; Tae-Hwi Schwantes-An; Jeffrey M Trent; Christopher A Haiman; M Cristina Leske; Suh-Yuh Wu; Joan E Bailey-Wilson; Barbara Nemesure
Journal:  Prostate       Date:  2014-09-22       Impact factor: 4.104

4.  Racial parity in tumor burden, treatment choice and survival outcomes in men with prostate cancer in the VA healthcare system.

Authors:  T J Daskivich; L Kwan; A Dash; M S Litwin
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-01-13       Impact factor: 5.554

5.  Five-Year Cancer Survival Rates in Oklahoma from 1997 to 2008.

Authors:  Janis Campbell; Krupa Gandhi; Anne Pate; Amanda Janitz; Amber Anderson; Robin Kinnard; Kai Ding
Journal:  J Okla State Med Assoc       Date:  2016 Jul-Aug

6.  Interplay of race, socioeconomic status, and treatment on survival of patients with prostate cancer.

Authors:  Kendra Schwartz; Isaac J Powell; Willie Underwood; Julie George; Cecilia Yee; Mousumi Banerjee
Journal:  Urology       Date:  2009-12       Impact factor: 2.649

7.  Racial variation in the quality of surgical care for prostate cancer.

Authors:  Daniel A Barocas; Darryl T Gray; Jay H Fowke; Nathaniel D Mercaldo; Jeffrey D Blume; Sam S Chang; Michael S Cookson; Joseph A Smith; David F Penson
Journal:  J Urol       Date:  2012-08-16       Impact factor: 7.450

8.  A comparison of ad hoc methods to account for non-cancer AIDS and deaths as competing risks when estimating the effect of HAART on incident cancer AIDS among HIV-infected men.

Authors:  Meredith S Shiels; Stephen R Cole; Joan S Chmiel; Joseph Margolick; Jeremy Martinson; Zuo-Feng Zhang; Lisa P Jacobson
Journal:  J Clin Epidemiol       Date:  2009-10-31       Impact factor: 6.437

9.  Socioeconomic status and prostate cancer incidence and mortality rates among the diverse population of California.

Authors:  Iona Cheng; John S Witte; Laura A McClure; Sarah J Shema; Myles G Cockburn; Esther M John; Christina A Clarke
Journal:  Cancer Causes Control       Date:  2009-06-13       Impact factor: 2.506

10.  Clinical presentation and initial management of black men and white men with prostate cancer in the United Kingdom: the PROCESS cohort study.

Authors:  S Evans; C Metcalfe; B Patel; F Ibrahim; K Anson; F Chinegwundoh; C Corbishley; D Gillatt; R Kirby; G Muir; V Nargund; R Popert; P Wilson; R Persad; Y Ben-Shlomo
Journal:  Br J Cancer       Date:  2009-11-24       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.